Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7,250 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Proteogenomic insights into early-onset endometrioid endometrial carcinoma: predictors for fertility-sparing therapy response.
Hu Z, Wu Z, Liu W, Ning Y, Liu J, Ding W, Fan J, Cai S, Li Q, Li W, Yang X, Dou Y, Wang W, Peng W, Lu F, Zhuang X, Qin T, Kang X, Feng C, Xu Z, Lv Q, Wang Q, Wang C, Wang X, Wang Z, Wang J, Jiang J, Wang B, Mills GB, Ma D, Gao Q, Li K, Chen G, Chen X, Sun C. Hu Z, et al. Among authors: lu f. Nat Genet. 2024 Apr;56(4):637-651. doi: 10.1038/s41588-024-01703-z. Epub 2024 Apr 2. Nat Genet. 2024. PMID: 38565644
Integrating pathology, chromosomal instability and mutations for risk stratification in early-stage endometrioid endometrial carcinoma.
Li Y, Li J, Guo E, Huang J, Fang G, Chen S, Yang B, Fu Y, Li F, Wang Z, Xiao R, Liu C, Huang Y, Wu X, Lu F, You L, Feng L, Xi L, Wu P, Ma D, Sun C, Wang B, Chen G. Li Y, et al. Among authors: lu f. Cell Biosci. 2020 Oct 22;10:122. doi: 10.1186/s13578-020-00486-0. eCollection 2020. Cell Biosci. 2020. PMID: 33110489 Free PMC article.
BRD4 inhibition impairs DNA mismatch repair, induces mismatch repair mutation signatures and creates therapeutic vulnerability to immune checkpoint blockade in MMR-proficient tumors.
Fu Y, Yang B, Cui Y, Hu X, Li X, Lu F, Qin T, Zhang L, Hu Z, Guo E, Fan J, Xiao R, Li W, Qin X, Hu D, Peng W, Liu J, Wang B, Mills GB, Chen G, Sun C. Fu Y, et al. Among authors: lu f. J Immunother Cancer. 2023 Apr;11(4):e006070. doi: 10.1136/jitc-2022-006070. J Immunother Cancer. 2023. PMID: 37072347 Free PMC article.
AZD5153 reverses palbociclib resistance in ovarian cancer by inhibiting cell cycle-related proteins and the MAPK/PI3K-AKT pathway.
Liu C, Huang Y, Qin T, You L, Lu F, Hu D, Xiao R, Qin X, Guo E, Yang B, Li X, Fan J, Li X, Fu Y, Liu S, Wang Z, Dou Y, Wang W, Li W, Yang X, Liu J, Peng W, Zhang L, Cui Y, Sun C, Chen G. Liu C, et al. Among authors: lu f. Cancer Lett. 2022 Mar 1;528:31-44. doi: 10.1016/j.canlet.2021.12.021. Epub 2021 Dec 20. Cancer Lett. 2022. PMID: 34942306
Inhibiting the IRE1α Axis of the Unfolded Protein Response Enhances the Antitumor Effect of AZD1775 in TP53 Mutant Ovarian Cancer.
Xiao R, You L, Zhang L, Guo X, Guo E, Zhao F, Yang B, Li X, Fu Y, Lu F, Wang Z, Liu C, Peng W, Li W, Yang X, Dou Y, Liu J, Wang W, Qin T, Cui Y, Zhang X, Li F, Jin Y, Zeng Q, Wang B, Mills GB, Chen G, Sheng X, Sun C. Xiao R, et al. Among authors: lu f. Adv Sci (Weinh). 2022 Jul;9(21):e2105469. doi: 10.1002/advs.202105469. Epub 2022 May 26. Adv Sci (Weinh). 2022. PMID: 35619328 Free PMC article.
7,250 results